The activation of FLSs results in over-production of pro-inflammatory cytokines, including tumour necrosis factor (TNF)-α and interleukin (IL)-1β, which are major factors in RA pathophysiology 2. The gene discussed is TNF; the disease is rheumatoid arthritis.